Replimune Group Inc Stock Price Today (NSE: REPL)

Replimune Group Inc

67.39+2.41 (+3.71%)
Market Closed

Fundamental Score

...

Replimune Group Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Replimune Group Inc share price today is 67.39, up +3.71% on NSE/BSE as of 7 August 2026. Replimune Group Inc (REPL) is a Small-cap company in the Civil Construction sector with a market capitalisation of 117.62 (Cr). The 52-week high for REPL share price is 182.80 and the 52-week low is 60.00. The company has a Return on Equity (ROE) of -7.57% and a debt-to-equity ratio of 0.20.

Replimune Group Inc Share Price Chart — NSE/BSE Historical Performance

No data
High
68.16
Low
61.32
Volume
4.9K
Change
-2.50%

Replimune Group Inc share price chart: -2.50% return over the past month. 52-week high ₹182.80, 52-week low ₹60.00.

Replimune Group Inc — Last 10 Trading Days

DateOpenHighLowCloseVolume
65.9765.9763.0764.983.46K (Cr)
65.0065.2464.0164.89991.00 (Cr)
62.1566.6762.1565.992.18K (Cr)
63.0066.6963.0065.082.28K (Cr)
65.5066.6563.1563.954.16K (Cr)
62.0066.7062.0065.583.71K (Cr)
65.1465.1462.0064.793.02K (Cr)
63.5965.9962.3263.552.82K (Cr)
66.7466.7463.0163.593.30K (Cr)
64.4566.0063.8264.5612.54K (Cr)

Replimune Group Inc — Last 12 Months Price History

MonthOpenHighLowCloseChange
63.0066.6962.1564.98+3.14%
68.1668.1661.3263.95-6.18%
69.6078.8063.0068.33-1.82%
82.1782.1768.9572.29-12.02%
64.9091.0064.8981.77+25.99%
85.1587.1860.0061.32-27.99%
111.40111.4085.6187.37-21.57%
118.01124.0087.27112.64-4.55%
127.55141.80115.70116.88-8.37%
142.47145.00124.00127.89-10.23%
148.06154.49138.51141.62-4.35%
161.00169.18141.00149.09-7.40%

Returns & Performance

Poor

Return on Equity (ROE)

-7.57%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-4.66%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

14.31%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Replimune Group Inc Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

17.15x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

68.64%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.14%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-872.83%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-43.08%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

2.54%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.20x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

-2.02x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-39.01 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Replimune Group Inc Fundamental Analysis & Valuation Benchmarking

Educational evaluation of REPL across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Conservative Debt Levels (D/E: 0.20)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Balanced Promoter Holding (68.64%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

9 factors identified

Below-Average Return on Equity (-7.57%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (-4.66%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-872.83%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-43.08%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (2.54% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Interest Coverage (-2.02x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-39.01 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.14%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Replimune Group Inc vs Civil Construction Peers

Peer Comparison - Civil Construction

Compare Replimune Group Inc with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
11.9/100
67
₹117.62
-7.57%
Poor
-4.66%
Poor
0.2
Excellent
2.54%
Average
0.00%
29.2/100
3939
₹520535.11
31.7
Average
15.86%
Good
14.57%
Average
1.1
Average
3.38%
Average
16.02%
Excellent
1.00%
27.7/100
225
₹47325.78
54.1
Average
9.02%
Poor
10.80%
Average
0.5
Excellent
-2.48%
Poor
5.79%
Good
0.76%
65.1/100
1368
₹27466.20
46.7
Average
27.80%
Excellent
32.76%
Excellent
0.4
Excellent
112.23%
Excellent
29.83%
Excellent
0.19%
55.8/100
95
₹26397.95
39.9
Average
24.08%
Excellent
30.95%
Excellent
0.0
Excellent
24.18%
Excellent
13.14%
Good
0.68%
41.7/100
20
₹24252.69
27.6
Average
4.31%
Poor
7.48%
Poor
1.0
Good
50.01%
Excellent
7.62%
Good
0.77%
32.8/100
1290
₹22154.34
22.6
Average
13.70%
Average
18.28%
Good
0.5
Excellent
13.35%
Good
15.95%
Excellent
0.85%
27/100
469
₹13509.65
20.8
Average
11.31%
Average
14.50%
Average
0.9
Good
3.49%
Average
12.38%
Good
1.08%
51.5/100
222
₹12942.12
18.7
Average
23.79%
Excellent
30.63%
Excellent
0.0
Excellent
15.77%
Excellent
4.55%
Average
1.74%
28.3/100
126
₹12258.63
20.6
Average
9.19%
Poor
9.69%
Poor
0.9
Good
9.00%
Good
11.17%
Good
2.03%
60.8/100
980
₹12201.05
27.2
Average
11.36%
Average
14.85%
Average
0.0
Excellent
25.15%
Excellent
29.77%
Excellent
0.86%

Replimune Group Inc PE Ratio History

Historical price-to-earnings ratio for REPL — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20217.73₹230.4029.8x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Replimune Group Inc Dividend History

Annual cash dividends paid by REPL — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 20220.69 Cr
FY 20210.43 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Replimune Group Inc Quarterly Performance

Latest quarterly metrics for REPL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-43.08%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-872.83%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

2.54%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Replimune Group Inc Technical Indicators

SMA 50, SMA 200, RSI and volume signals for REPL — calculated from daily price history

39RSI 14
Neutral — RSI 39

Momentum is balanced — neither overbought nor oversold.

SMA 50
68
▼ Price below SMA 50 — Short-term bearish
SMA 200
97
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
5K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Replimune Group Inc Financial Statements

Annual income statement, balance sheet and cash flow for Replimune Group Inc (REPL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Replimune Group Inc

About REPL (Replimune Group Inc)

Replimune Group Inc is reimagining civil construction through its innovative bio-construction approach, seamlessly integrating engineered living materials with traditional infrastr...ucture development. By harnessing the natural capabilities of microorganisms and plant life, Replimune crafts self-healing concrete, bio-receptive facades, and soil-stabilizing solutions. These biomaterials not only reduce the carbon footprint associated with conventional construction methods but also offer enhanced durability and adaptability to changing environmental conditions. Focusing on sustainable and resilient infrastructure, Replimune aims to revolutionize how we build and interact with our urban landscapes, promoting ecological harmony and long-term cost-effectiveness. The company's expertise extends across various sectors, including transportation, water management, and landscape architecture. Replimune provides comprehensive bio-construction services, encompassing material design and development, structural analysis, and on-site implementation. Their team of bio-engineers, architects, and construction specialists collaborate closely with clients to develop customized solutions that address specific project needs and environmental concerns. By incorporating living systems into the built environment, Replimune aims to create infrastructure that not only performs optimally but also actively contributes to ecological restoration and improved air quality. Replimune's commitment to sustainable innovation extends beyond material science to embrace collaborative partnerships with local communities and research institutions. Through these collaborations, the company seeks to advance the understanding and application of bio-construction principles, fostering a more sustainable and resilient future for the civil construction industry. By integrating cutting-edge research with practical application, Replimune is paving the way for a new era of infrastructure development that prioritizes environmental stewardship and long-term societal benefits. Their holistic approach aims to transform cities into living ecosystems that thrive in harmony with nature.

Company Details

Symbol:REPL
Industry:Civil Construction
Sector:Civil Construction

Key Leadership

Mr. Pradeep Misra
Chairman & MD
Mr. Manoj Kumar
Chief Financial Officer
Mr. Rahas Bihari Panda
Company Secretary & Compliance Officer

REPL Share Price: Frequently Asked Questions

What is the current share price of Replimune Group Inc?

Replimune Group Inc (REPL) trades at ₹67.39 on NSE. Market cap ₹117.62 (Cr). Educational data only.

What is the P/E ratio of Replimune Group Inc?

Replimune Group Inc has a P/E of N/Ax vs industry average 17.15x.

What is the Bull Run score for Replimune Group Inc?

Replimune Group Inc has a Bull Run score of 11.9/100 based on 25+ financial parameters.

Does Replimune Group Inc pay dividends?

Replimune Group Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Replimune Group Inc?

Replimune Group Inc has ROE of -7.57%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Replimune Group Inc?

Replimune Group Inc has debt-to-equity of 0.20.

Is Replimune Group Inc a good investment?

Bull Run gives Replimune Group Inc a score of 11.9/100. This is not investment advice — consult a SEBI-registered advisor.